Results 21 to 30 of about 9,180 (218)

The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer

open access: yesJournal of Hepatocellular Carcinoma
Purpose The prevalence of primary liver cancer (PLC) is rising, yet strategies for its early diagnosis remain inadequate. This study aims to identify novel biomarkers to improve the diagnostic ability of PLC.
Yue Liu   +4 more
semanticscholar   +4 more sources

Lateral Flow Immunoassay Based on Time-Resolved Fluorescence Microspheres for Rapid and Quantitative Screening CA199 in Human Serum

open access: yesInternational Journal of Molecular Sciences, 2022
Carbohydrate antigen 199 (CA199) is a serum biomarker which has certain value and significance in the diagnosis, prognosis, treatment, and postoperative monitoring of cancer.
Xueshima Jiao   +11 more
semanticscholar   +3 more sources

Serum CA125, CA199 and CEA Combined Detection for Epithelial Ovarian Cancer Diagnosis: A Meta-analysis

open access: yesOpen Medicine, 2017
Objective To evaluate the diagnostic value of combination detection of serum cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA199) and carci noembryonic antigen(CEA) in patients with epithelial ovarian cancer by pooling the open published studies
Junhong Guo   +3 more
semanticscholar   +4 more sources

Prognostic value of perioperative NER levels combined with Ca199 in cholangiocarcinoma surgery.

open access: yesCurrent Problems in Surgery
Jie Chen   +10 more
semanticscholar   +3 more sources

Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer

open access: yesOncology Letters, 2019
Application values of CA125 combined with CA199 and ultrasound combined with computed tomography (CT) in the clinical diagnosis of ovarian cancer were compared.
Bingcheng Guo   +4 more
semanticscholar   +4 more sources

Association between serum tumor markers and diabetic nephropathy in type 2 diabetes patients: a cross-sectional survey in Western China [PDF]

open access: yesBMC Endocrine Disorders
Background Diabetic nephropathy (DN) is a common and serious microvascular complication of type 2 diabetes mellitus (T2DM). However, there is limited clinical research on the use of tumor markers in DN, and the relationship between serum tumor markers ...
Li Tao   +11 more
doaj   +2 more sources

Analysis of the prognostic survival of Ki67, CEA, CA199 and relevant clinical pathological features in metastatic colorectal cancer

open access: yes结直肠肛门外科, 2023
[Objectives] To analyze the relationship between Ki67, CEA, CA199, and relevant clinical pathological features and the prognostic survival of metastatic colorectal cancer (mCRC).
Huang Jian   +4 more
doaj   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Clinical Value of Platelet and Its Parameters Combined with Tumor Markers in Preoperative Differentiation of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To evaluate the value of PLT and its parameters combined with AFP, CA199, CA125 and CEA on the preoperative differential diagnosis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).
ZHANG Haodong   +3 more
doaj   +1 more source

Difference of serum tumor markers in different clinical stages of elderly patients with non-small cell lung cancer and evaluation of diagnostic value [PDF]

open access: yesJournal of Medical Biochemistry, 2023
Background: To explore the difference and diagnostic value evaluation of serum tumor markers in different clinical stages of elderly non-small cell lung cancer (NSCLC) patients.
Qin Wen Wen   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy